Loading
Latest filing published 16 Aug 2018 for Khiron Life Sciences Corp..
No signal scores available.
Andres Eduardo Torres discloses dealings in Khiron Life Sciences Corp. to SEDI. We count 2 filings, every one of them for a trade on 24 May 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 16 August 2018 came the latest disclosure, a transaction in Khiron Life Sciences Corp. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations